VIVS VivoSim Labs, Inc.
$0.15▼ -1.12%
Healthcare
Other
After hours
$0.15▼ -0.20%
Oct 27, 6:01 PM ET
Volume 475.9K
Avg Volume (10D) 1.25M
Key Metrics & Fundamentals
Market Cap
$2.49M
P/E Ratio
0.5
Div Yield
0.00%
52W Range
0.14 - 3.40
% vs 50 MA
-34.94%
% vs 200 MA
-86.35%
RSI-14
29.8
MACD Histogram
+0.0000
Beta (1Y vs SPY)
1.55
Free Cash Flow
-$3.24M
Gross Rev
$18,000
Gross Profit
$18,000
EBITDA
-$2.69M
COGS
–
Operating Exp
$2.78M
Operating Income
-$2.76M
EBIT
-$2.76M
Pretax Income
-$1.34M
Net Income
-$1.34M
EPS (Diluted)
-0.25
Price & Volume History
Loading chart…
Recent News
VivoSim Labs Extends NAMkind Platform with Human Disease Models for Efficacy Testing and Mechanistic Biomarker Profiling
GlobeNewswire · Oct 21, 2026 8:05 AM ET
VivoSim Labs Celebrates Updated FDA Regulations Allowing Greater use of Non-Animal Testing Methods
GlobeNewswire · Oct 7, 2026 8:05 AM ET
VivoSim Labs Unveils New NAMkind™ Drug Toxicity Data at EUROTOX 2026, Demonstrating Predictive Superiority in Liver and Gastrointestinal Safety Across Small Molecules and ADCs
GlobeNewswire · Sep 16, 2026 8:05 AM ET
VivoSim Labs to Add Rat Liver Model to NAMkind Platform
GlobeNewswire · Sep 1, 2026 8:05 AM ET
VivoSim: Fiscal Q1 Earnings Snapshot
Associated Press · Aug 12, 2026 5:52 PM ET
BC-Most Active Stocks
Associated Press · Aug 7, 2026 10:30 AM ET
VivoSim Provides Financial and Listing Compliance Update
GlobeNewswire · Aug 6, 2026 8:05 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See VIVS's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.